Are peptides legal in Arkansas?
Peptide drugs are federally regulated. State pharmacy law governs compounding and dispensing, and the state board follows FDA 503A/503B bulk-substance rules. Arkansas requires in-state pharmacy licensure for shipment and limits initial telehealth prescribing for some therapies.
Compounding
Strict board oversight
Primary citations
- Ark. Code § 17-92-101
What this means practically
Approved peptide drugs such as semaglutide, tirzepatide, and tesamorelin are obtainable in Arkansas with a valid prescription from a licensed practitioner, dispensed by a licensed pharmacy. Telehealth access is limited.
Peptides on the FDA's 503A Category 2 bulk list — including BPC-157, CJC-1295, ipamorelin, and thymosin alpha-1 — cannot lawfully be compounded by any pharmacy in Arkansas, regardless of state rules, because the restriction is federal. Products sold online as "research chemicals" are not approved for human use.
This page tracks status only. It is not legal advice, and state boards update guidance frequently.